MAPK8 and nasopharyngeal carcinoma: To further confirm the nicotine-induced activation of the ERK/MAPK pathway in NPC cells, we next analyzed the effects of the ERK, JNK and P38-selective inhibitors (U0126, SB203580, SP600125) on nicotine-mediated proliferation promotion in NPC cells.